PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for the Company’s ...
Derma Sciences CEO Ed Quilty stated, "We are fully aware that, although the benefits of MEDIHONEY have captured the imagination of the public and the medical community alike, it is only through ...
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has purchased the MEDIHONEY® brand ...
PRINCETON, N.J., Oct. 22 Derma Sciences, Inc.(OTC Bulletin Board: DSCI), a company specializing in advanced wound care,today announced that eleven clinical posters focusing on its new technologieshave ...
Derma Sciences' CEO Edward J. Quilty said, "This is another important milestone for the MEDIHONEY product line. We expect the tube version to be one of the most popular in the line, due to its ease of ...
Comvita’s global licensee for Medihoney ® specialist wound care products, Derma Sciences Inc has announced it has achieved a key milestone for sales of MEDIHONEY® . Under the terms of its exclusive ...
Medihoney™antibacterial Leptospermum (Manuka) honey eradicates MRSA from 70% of chronic venous ulcers and stimulates healing in chronic wounds Superbug – methicillin-resistant Staphylococcus aureus ...
Surviving cancer is physically and emotionally exhausting. But for many patients, beating the disease itself is just the first hurdle. A second ordeal comes from living with the fungating tumor wounds ...
Add articles to your saved list and come back to them any time. Natural healthcare products company Comvita is to buy Australian firm Medihoney in an $A6 million deal ...
England all-rounder Moeen Ali has revealed how an anonymous worker from the National Health Service (NHS) helped him with an injury during the Ashes. The veteran spinner disclosed that the medical ...
* Derma sciences inc - consideration is an upfront payment of $13.25 million in cash * Derma sciences inc -deal includes an additional $5.0 million potentially payable in form of an earn-out upon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results